Sign in

CIK 0001712762

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

bioAffinity Technologies, Inc.

Sign in to watch
Ticker
BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465211056
Phone
+1 210-698-5334
Business address
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
Former names
bioAffinity Technologies, Inc.

Securities

  • BIAF Common Stock Nasdaq
  • BIAFW Warrant Nasdaq
  1. 4 Grant or award Director acquired 24,535 shares (grant or award)
  2. 4 Grant or award Director acquired 11,867 shares (grant or award)
  3. 4 Grant or award Director acquired 24,535 shares (grant or award)
  4. 4 Grant or award Director acquired 24,535 shares (grant or award)
  5. 4 Grant or award Director acquired 12,668 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Executive Chairman acquired 54,707 shares (grant or award)
  10. 4 Grant or award Director acquired 28,392 shares (grant or award)
  11. 4 Grant or award Director acquired 28,392 shares (grant or award)
  12. 4 Grant or award Director acquired 28,392 shares (grant or award)
  13. 4 Grant or award Executive Chairman acquired 28,392 shares (grant or award)
  14. 4 Grant or award Director acquired 28,392 shares (grant or award)
  15. 4 Grant or award President, CEO acquired 54,570 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 52,356 shares (grant or award)
  17. 4 Grant or award Director acquired 28,392 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Conversion 10% owner acquired 161,820 shares (conversion)
  20. 3 Insider Initial Statement of Ownership

Page 3 of 4 · 80 filings